­
­
­
­

Inventi Impact: Cardiovascular Nursing

Articles

  • Inventi:hcvn/30624/19
    Mineralocorticoid Receptor Antagonist Use After Hospitalization of Patients with Heart Failure and Post-Discharge Outcomes: A Single-Center Retrospective Cohort Study
    Research 2020 : January - March
    Matthew S Durstenfeld, Stuart D Katz, Hannah Park, Saul Blecker

    Background: Mineralocorticoid receptor antagonists (MRA) are an underutilized therapy for heart failure with a reduced\nejection fraction (HFrEF), but the current impact of hospitalization on MRA use is not well characterized. The objective of\nthis study was to describe contemporary MRA prescription for heart failure patients before and after the full scope of\nhospitalizations and the association between MRA discharge prescription and post-hospitalization outcomes.\nMethods: We conducted a retrospective cohort study at an academic hospital system in 2013-2016. Among 1500\nincluded hospitalizations of 1009 unique patients with HFrEF and without MRA contraindication, the mean age was................

    How to Cite this Article
    Attribution/ CC Compliant Citation: Durstenfeld et al; Mineralocorticoid receptor antagonist use after hospitalization of\npatients with heart failure and post-discharge outcomes: a single-center retrospective cohort study; BMC Cardiovascular\nDisorders (2019) 19:194.\nhttps://doi.org/10.1186/s12872-019-1175-3\nhttp://creativecommons.org/licenses/by/4.0/\nSome formatting elements, header, footer, logos, dates and pagination were modified while adapting this article.\n
    Download Full Text